Znanstveni rad - Izvorni znanstveni rad
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events
Journal of the American College of Cardiology, 73 (2019), 4; 387-396. https://doi.org/10.1016/j.jacc.2018.10.039

(ODYSSEY OUTCOMES) Szarek, Michael; White, Harvey D.; Schwartz, Gregory G.; Alings, Marco; Bhatt, Deepak L.; Bittner, Vera A.; Chiang, Chern-En; Diaz, Rafael; Edelberg, Jay M.; Goodman, Shaun G.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J. Wouter; Kimura, Takeshi; Kiss, Robert Gabor; Lecorps, Guillaume; Mahaffey, Kenneth W.; Moryusef, Angèle; Pordy, Robert; Roe, Matthew T.; Tricoci, Pierluigi; Xavier, Denis; Zeiher, Andreas M.; Steg, Ph. Gabriel; Reiner, Željko; Peršić, Viktor; Tomulić, Vjekoslav Više autora...

Citirajte ovaj rad

Szarek, M., White, H. D., Schwartz, G. G., Alings, M., Bhatt, D. L., Bittner, V. A. ... Tomulić, V. (2019). Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events. Journal of the American College of Cardiology, 73. (4), 387-396. doi: 10.1016/j.jacc.2018.10.039

Szarek, Michael, et al. "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events." Journal of the American College of Cardiology, vol. 73, br. 4, 2019, str. 387-396. https://doi.org/10.1016/j.jacc.2018.10.039

Szarek, Michael, Harvey D. White, Gregory G. Schwartz, Marco Alings, Deepak L. Bhatt, Vera A. Bittner, Chern En Chiang, et al. "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events." Journal of the American College of Cardiology 73, br. 4 (2019): 387-396. https://doi.org/10.1016/j.jacc.2018.10.039

Szarek, M., et al. (2019) 'Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events', Journal of the American College of Cardiology, 73(4), str. 387-396. doi: 10.1016/j.jacc.2018.10.039

Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, i sur.. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events. Journal of the American College of Cardiology [Internet]. 2019. [pristupljeno 20.06.2024.];73(4):387-396. doi: 10.1016/j.jacc.2018.10.039

M. Szarek, et al., "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events", Journal of the American College of Cardiology, vol. 73, br. 4, str. 387-396, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:149856. [Citirano: 20.06.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.